Xylem Inc.XYLEarnings & Financial Report
Xylem is one of the two types of transport tissue in vascular plants, the other being phloem; both of these are part of the vascular bundle. The basic function of the xylem is to transport water upward from the roots to parts of the plants such as stems and leaves, but it also transports nutrients. The word xylem is derived from the Ancient Greek word ξύλον (xúlon), meaning "wood"; the best-known xylem tissue is wood, though it is found throughout a plant.
Revenue
$2.0B
Gross Profit
$752.0M
Operating Profit
$209.0M
Net Profit
$153.0M
Gross Margin
37.0%
Operating Margin
10.3%
Net Margin
7.5%
YoY Growth
40.4%
EPS
$0.63
Financial Flow
Xylem Inc. Q1 2024 Financial Summary
Xylem Inc. reported revenue of $2.0B (up 40.4% YoY) for Q1 2024, with a net profit of $153.0M (up 54.5% YoY) (7.5% margin). Cost of goods sold was $1.3B, operating expenses totaled $543.0M.
Key Financial Metrics
| Total Revenue | $2.0B |
|---|---|
| Net Profit | $153.0M |
| Gross Margin | 37.0% |
| Operating Margin | 10.3% |
| Report Period | Q1 2024 |
Revenue Breakdown
Xylem Inc. Q1 2024 revenue of $2.0B breaks down across 8 segments, led by Evoqua Acquisition at $480.0M (23.6% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Evoqua Acquisition | $480.0M | 23.6% |
| Public Utilities Inventory Water | $377.0M | 18.5% |
| Commercial Building Services | $240.0M | 11.8% |
| Treatment | $237.0M | 11.7% |
| Applied Water | $232.0M | 11.4% |
| Water Infrastructure | $204.0M | 10.0% |
| Industrial Water | $196.0M | 9.6% |
| Electric | $85.0M | 4.2% |
Xylem Inc. Revenue by Segment — Quarterly Trend
Xylem Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Evoqua Acquisition and Public Utilities Inventory Water) has evolved quarter over quarter.
| Segment | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Commercial Building Services | — | $260.0M | — | — |
| Treatment | — | $279.0M | $265.0M | — |
| Applied Water | — | — | — | $239.0M |
Xylem Inc. Annual Revenue by Year
Xylem Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $9.0B).
| Year | Annual Revenue |
|---|---|
| 2025 | $9.0B |
| 2024 | $8.6B |
| 2023 | $7.4B |
| 2022 | $5.5B |
Xylem Inc. Quarterly Revenue & Net Profit History
Xylem Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $2.4B | +6.3% | $335.0M | 14.0% |
| Q3 2025 | $2.3B | +7.8% | $227.0M | 10.0% |
| Q2 2025 | $2.3B | +6.1% | $226.0M | 9.8% |
| Q1 2025 | $2.1B | +1.8% | $169.0M | 8.2% |
| Q4 2024 | $2.3B | +6.5% | $326.0M | 14.5% |
| Q3 2024 | $2.1B | +1.3% | $217.0M | 10.3% |
| Q2 2024 | $2.2B | +26.0% | $194.0M | 8.9% |
| Q1 2024 | $2.0B | +40.4% | $153.0M | 7.5% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.03B | $2.17B | $2.10B | $2.26B | $2.07B | $2.30B | $2.27B | $2.40B |
| YoY Growth | 40.4% | 26.0% | 1.3% | 6.5% | 1.8% | 6.1% | 7.8% | 6.3% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $15.92B | $15.77B | $16.05B | $16.49B | $16.56B | $17.19B | $17.30B | $17.63B |
| Liabilities | $5.72B | $5.42B | $5.45B | $5.61B | $5.50B | $5.88B | $5.85B | $5.88B |
| Equity | $10.20B | $10.34B | $10.59B | $10.64B | $10.82B | $11.07B | $11.21B | $11.48B |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $89.0M | $288.0M | $311.0M | $575.0M | $33.0M | $305.0M | $360.0M | $543.0M |